Do analysts recommend MNY or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MoneyHero 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is MNY or SYRA more profitable?

MoneyHero has a net margin of -12.53% compared to Syra Health's net margin of -54.90%. MoneyHero's return on equity of -16.25% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets MoneyHero -12.53% -16.25% -8.38% Syra Health -54.90% -131.94% -99.19%

Does the media prefer MNY or SYRA?

In the previous week, MoneyHero had 5 more articles in the media than Syra Health. MarketBeat recorded 7 mentions for MoneyHero and 2 mentions for Syra Health. Syra Health's average media sentiment score of 0.37 beat MoneyHero's score of 0.12 indicating that Syra Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MoneyHero 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Syra Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer SYRA or BRAG?

Bragg Gaming Group has a consensus price target of $5.33, suggesting a potential upside of 231.26%. Given Bragg Gaming Group's stronger consensus rating and higher probable upside, analysts plainly believe Bragg Gaming Group is more favorable than Syra Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bragg Gaming Group 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend HGBL or SYRA?

Heritage Global currently has a consensus target price of $4.50, suggesting a potential upside of 273.44%. Given Heritage Global's stronger consensus rating and higher possible upside, analysts plainly believe Heritage Global is more favorable than Syra Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heritage Global 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer SYRA or SWAG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Stran & Company, Inc. 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer SYRA or SWAG?

In the previous week, Stran & Company, Inc. had 3 more articles in the media than Syra Health. MarketBeat recorded 5 mentions for Stran & Company, Inc. and 2 mentions for Syra Health. Stran & Company, Inc.'s average media sentiment score of 0.97 beat Syra Health's score of 0.37 indicating that Stran & Company, Inc. is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Syra Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Stran & Company, Inc. 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Syra Health (SYRA) Competitors

$0.70 +0.03 (+4.48%)

As of 01:06 PM Eastern

Compare

SYRA vs. MNY, BRAG, HGBL, LUNA, and SWAG

Should you buy Syra Health stock or one of its competitors? MarketBeat compares Syra Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Syra Health include MoneyHero (MNY), Bragg Gaming Group (BRAG), Heritage Global (HGBL), Luna Innovations (LUNA), and Stran & Company, Inc. (SWAG). These companies are all part of the "business services" industry.

How does Syra Health compare to MoneyHero?

MoneyHero (NASDAQ:MNY) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

MoneyHero has a net margin of -12.53% compared to Syra Health's net margin of -54.90%. MoneyHero's return on equity of -16.25% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MoneyHero	-12.53%	-16.25%	-8.38%
Syra Health	-54.90%	-131.94%	-99.19%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MoneyHero	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

30.9% of MoneyHero shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 19.2% of MoneyHero shares are held by insiders. Comparatively, 36.5% of Syra Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Syra Health has lower revenue, but higher earnings than MoneyHero. Syra Health is trading at a lower price-to-earnings ratio than MoneyHero, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MoneyHero	$75.63M	0.57	-$5.18M	-$0.30	N/A
Syra Health	$7.98M	1.21	-$2.94M	-$0.02	N/A

In the previous week, MoneyHero had 5 more articles in the media than Syra Health. MarketBeat recorded 7 mentions for MoneyHero and 2 mentions for Syra Health. Syra Health's average media sentiment score of 0.37 beat MoneyHero's score of 0.12 indicating that Syra Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MoneyHero	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Syra Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

MoneyHero has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market. Comparatively, Syra Health has a beta of 2.94, indicating that its share price is 194% more volatile than the broader market.

Summary

MoneyHero and Syra Health tied by winning 7 of the 14 factors compared between the two stocks.

How does Syra Health compare to Bragg Gaming Group?

Syra Health (NASDAQ:SYRA) and Bragg Gaming Group (NASDAQ:BRAG) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

4.8% of Syra Health shares are held by institutional investors. Comparatively, 4.0% of Bragg Gaming Group shares are held by institutional investors. 36.5% of Syra Health shares are held by insiders. Comparatively, 26.4% of Bragg Gaming Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Bragg Gaming Group has a consensus price target of $5.33, suggesting a potential upside of 231.26%. Given Bragg Gaming Group's stronger consensus rating and higher probable upside, analysts plainly believe Bragg Gaming Group is more favorable than Syra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bragg Gaming Group	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Syra Health has higher earnings, but lower revenue than Bragg Gaming Group. Syra Health is trading at a lower price-to-earnings ratio than Bragg Gaming Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.21	-$2.94M	-$0.02	N/A
Bragg Gaming Group	$119.98M	0.41	-$9.18M	-$0.31	N/A

Syra Health has a beta of 2.94, meaning that its share price is 194% more volatile than the broader market. Comparatively, Bragg Gaming Group has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

Bragg Gaming Group has a net margin of -6.27% compared to Syra Health's net margin of -54.90%. Bragg Gaming Group's return on equity of -10.65% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Bragg Gaming Group	-6.27%	-10.65%	-6.92%

In the previous week, Syra Health had 1 more articles in the media than Bragg Gaming Group. MarketBeat recorded 2 mentions for Syra Health and 1 mentions for Bragg Gaming Group. Bragg Gaming Group's average media sentiment score of 1.87 beat Syra Health's score of 0.37 indicating that Bragg Gaming Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Syra Health	Neutral
Bragg Gaming Group	Very Positive

Summary

Syra Health and Bragg Gaming Group tied by winning 8 of the 16 factors compared between the two stocks.

How does Syra Health compare to Heritage Global?

Heritage Global (NASDAQ:HGBL) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

In the previous week, Heritage Global and Heritage Global both had 2 articles in the media. Heritage Global's average media sentiment score of 1.44 beat Syra Health's score of 0.37 indicating that Heritage Global is being referred to more favorably in the media.

Company	Overall Sentiment
Heritage Global	Positive
Syra Health	Neutral

Heritage Global has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Heritage Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heritage Global	$50.98M	0.82	$3.59M	$0.10	12.05
Syra Health	$7.98M	1.21	-$2.94M	-$0.02	N/A

Heritage Global currently has a consensus target price of $4.50, suggesting a potential upside of 273.44%. Given Heritage Global's stronger consensus rating and higher possible upside, analysts plainly believe Heritage Global is more favorable than Syra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heritage Global	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Heritage Global has a net margin of 6.45% compared to Syra Health's net margin of -54.90%. Heritage Global's return on equity of 4.86% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heritage Global	6.45%	4.86%	3.73%
Syra Health	-54.90%	-131.94%	-99.19%

33.5% of Heritage Global shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 15.6% of Heritage Global shares are held by company insiders. Comparatively, 36.5% of Syra Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Heritage Global has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market. Comparatively, Syra Health has a beta of 2.94, meaning that its stock price is 194% more volatile than the broader market.

Summary

Heritage Global beats Syra Health on 13 of the 16 factors compared between the two stocks.

How does Syra Health compare to Luna Innovations?

Syra Health (NASDAQ:SYRA) and Luna Innovations (NASDAQ:LUNA) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

Luna Innovations has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Luna Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.21	-$2.94M	-$0.02	N/A
Luna Innovations	$116.61M	0.36	$9.28M	$0.06	20.83

In the previous week, Syra Health had 2 more articles in the media than Luna Innovations. MarketBeat recorded 2 mentions for Syra Health and 0 mentions for Luna Innovations. Syra Health's average media sentiment score of 0.37 beat Luna Innovations' score of 0.00 indicating that Syra Health is being referred to more favorably in the media.

Company	Overall Sentiment
Syra Health	Neutral
Luna Innovations	Neutral

Syra Health has a beta of 2.94, meaning that its stock price is 194% more volatile than the broader market. Comparatively, Luna Innovations has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market.

4.8% of Syra Health shares are held by institutional investors. Comparatively, 87.5% of Luna Innovations shares are held by institutional investors. 36.5% of Syra Health shares are held by company insiders. Comparatively, 7.6% of Luna Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Luna Innovations has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Luna Innovations' return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Luna Innovations	N/A	N/A	N/A

Summary

Luna Innovations beats Syra Health on 8 of the 13 factors compared between the two stocks.

How does Syra Health compare to Stran & Company, Inc.?

Syra Health (NASDAQ:SYRA) and Stran & Company, Inc. (NASDAQ:SWAG) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Stran & Company, Inc.	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Stran & Company, Inc. has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Stran & Company, Inc., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.21	-$2.94M	-$0.02	N/A
Stran & Company, Inc.	$116.19M	0.31	-$750K	$0.01	195.90

Stran & Company, Inc. has a net margin of 0.33% compared to Syra Health's net margin of -54.90%. Stran & Company, Inc.'s return on equity of 1.26% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Stran & Company, Inc.	0.33%	1.26%	0.73%

4.8% of Syra Health shares are owned by institutional investors. Comparatively, 56.4% of Stran & Company, Inc. shares are owned by institutional investors. 36.5% of Syra Health shares are owned by insiders. Comparatively, 50.6% of Stran & Company, Inc. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Syra Health has a beta of 2.94, suggesting that its stock price is 194% more volatile than the broader market. Comparatively, Stran & Company, Inc. has a beta of 1.97, suggesting that its stock price is 97% more volatile than the broader market.

In the previous week, Stran & Company, Inc. had 3 more articles in the media than Syra Health. MarketBeat recorded 5 mentions for Stran & Company, Inc. and 2 mentions for Syra Health. Stran & Company, Inc.'s average media sentiment score of 0.97 beat Syra Health's score of 0.37 indicating that Stran & Company, Inc. is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Syra Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Stran & Company, Inc.	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Stran & Company, Inc. beats Syra Health on 12 of the 14 factors compared between the two stocks.

Get Syra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYRA vs. The Competition

Export

Metric	Syra Health	Employment agencies Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.69M	$16.44M	$6.92B	$12.17B
Dividend Yield	N/A	N/A	2.67%	9.81%
P/E Ratio	-1.08	N/A	27.12	23.76
Price / Sales	1.21	0.74	528.45	92.21
Price / Cash	N/A	N/A	26.39	46.67
Price / Book	1.13	0.70	10.45	6.16
Net Income	-$2.94M	-$13.52M	$3.60B	$331.26M
7 Day Performance	-7.89%	-4.90%	-1.25%	-0.03%
1 Month Performance	29.63%	16.03%	-2.58%	-2.50%
1 Year Performance	N/A	-8.66%	18.50%	13.99%

Syra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYRA Syra Health	N/A	$0.70 +4.5%	N/A	+570.0%	$9.69M	$7.98M	N/A	78	Gap Down
MNY MoneyHero	0.738 of 5 stars	$0.97 flat	N/A	-53.1%	$42.51M	$73.43M	N/A	359	News Coverage Analyst Upgrade Analyst Revision
BRAG Bragg Gaming Group	3.5579 of 5 stars	$1.61 -4.2%	$5.33 +231.3%	-62.4%	$42.07M	$119.98M	N/A	290
HGBL Heritage Global	4.6471 of 5 stars	$1.20 -0.8%	$4.50 +275.0%	-44.2%	$42.03M	$50.98M	12.00	60	Short Interest Decrease
LUNA Luna Innovations	N/A	$1.23 -0.8%	N/A	+24.0%	$41.77M	$116.61M	20.50	390

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SYRA) was last updated on 7/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Syra Health (SYRA) Competitors

SYRA vs. MNY, BRAG, HGBL, LUNA, and SWAG

How does Syra Health compare to MoneyHero?

Summary

How does Syra Health compare to Bragg Gaming Group?

Summary

How does Syra Health compare to Heritage Global?

Summary

How does Syra Health compare to Luna Innovations?

Summary

How does Syra Health compare to Stran & Company, Inc.?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Syra Health (SYRA) Competitors

SYRA vs. MNY, BRAG, HGBL, LUNA, and SWAG

How does Syra Health compare to MoneyHero?

Is MNY or SYRA more profitable?

Do analysts recommend MNY or SYRA?

Do institutionals and insiders have more ownership in MNY or SYRA?

Which has higher earnings and valuation, MNY or SYRA?

Does the media prefer MNY or SYRA?

Which has more risk and volatility, MNY or SYRA?

Summary

How does Syra Health compare to Bragg Gaming Group?

Do institutionals & insiders have more ownership in SYRA or BRAG?

Do analysts prefer SYRA or BRAG?

Which has better earnings and valuation, SYRA or BRAG?

Which has more risk and volatility, SYRA or BRAG?

Is SYRA or BRAG more profitable?

Does the media favor SYRA or BRAG?

Summary

How does Syra Health compare to Heritage Global?

Does the media favor HGBL or SYRA?

Which has better earnings and valuation, HGBL or SYRA?

Do analysts recommend HGBL or SYRA?

Is HGBL or SYRA more profitable?

Do insiders & institutionals believe in HGBL or SYRA?

Which has more risk & volatility, HGBL or SYRA?

Summary

How does Syra Health compare to Luna Innovations?

Which has higher earnings and valuation, SYRA or LUNA?

Does the media favor SYRA or LUNA?

Which has more risk & volatility, SYRA or LUNA?

Do institutionals & insiders believe in SYRA or LUNA?

Is SYRA or LUNA more profitable?

Summary

How does Syra Health compare to Stran & Company, Inc.?

Do analysts prefer SYRA or SWAG?

Which has better valuation and earnings, SYRA or SWAG?

Is SYRA or SWAG more profitable?

Do institutionals & insiders hold more shares of SYRA or SWAG?

Which has more volatility and risk, SYRA or SWAG?

Does the media prefer SYRA or SWAG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools